Hazard ratio | 95% CI | Ρ value | |
---|---|---|---|
Age (continuous - per year) | 1.03 | 1.03–1.04 | < 0.001 |
Age group at study entry | |||
16–49 (ref) | |||
50–59 | 1.19 | 1.07–1.32 | < 0.001 |
Sex | |||
Male (ref) | |||
Female | 0.91 | 0.85–0.98 | 0.009 |
Geographic region | |||
West (ref) | |||
East | 1.05 | 0.95–1.17 | 0.345 |
Berlin | 1.42 | 1.27–1.59 | < 0.001 |
Month of vaccination | |||
January (ref) | |||
February | 0.64 | 0.52–0.79 | < 0.001 |
March | 0.82 | 0.55–1.22 | 0.329 |
April | 0.93 | 0.66–1.30 | 0.675 |
May | 0.62 | 0.50–0.78 | < 0.001 |
June | 0.97 | 0.65–1.44 | 0.873 |
July | 1.03 | 0.74–1.43 | 0.869 |
August | 0.68 | 0.54–0.84 | 0.001 |
September | 1.12 | 0.75–1.67 | 0.590 |
October | 1.23 | 0.88–1.72 | 0.216 |
November | 0.67 | 0.53–0.83 | < 0.001 |
December | 0.81 | 0.47–1.37 | 0.424 |
Influenza vaccination status | |||
Unvaccinated (ref) | |||
Vaccinated | 4.96 | 4.59–5.36 | < 0.001 |
First risk condition diagnosed | |||
At-risk (ref) | |||
High-risk | 0.69 | 0.61–0.79 | < 0.001 |
At-risk status | |||
1 at-risk condition, no high-risk condition (ref) | |||
2 at-risk conditions, no high-risk condition | 2.40 | 2.14–2.69 | < 0.001 |
3 or more at-risk conditions, no high-risk condition | 3.82 | 2.79–5.22 | < 0.001 |
1 high-risk condition | 3.63 | 3.19–4.13 | < 0.001 |
2 high-risk conditions | 9.77 | 8.29–11.50 | < 0.001 |
3 or more high-risk conditions | 22.62 | 18.27–28.00 | < 0.001 |